Manufacturers trying to implement these approaches must deliver robust validation knowledge to reveal their equivalence to pharmacopoeial strategies. The WHO guidelines stipulate that manufacturers have to produce and adhere to in-depth servicing schedules depending on products requirements and utilization patterns. An overpressure (10 to one hundred Pa) prevails while Successfully Submitted (Awaiting Approval)